When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ETTX - Zai Lab on go with China study of antibiotic combo
Entasis Therapeutics Holdings Inc.
The China National Medical Products Administration has signed off on Zai Lab's (ZLAB-4%) application to conduct a Phase 3 clinical trial there evaluating ETX2514SUL, a fixed-dose combination of a broad spectrum ?-lactamase inhibitor with sulbactam, for the treatment of pneumonia and blood stream infections caused by carbapenem-resistant the bacterium A. baumannii.
More news on: Zai Lab Limited, Entasis Therapeutics, Healthcare stocks news,